Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?Friday, August 9, 2024Availability, Epidemiological impactRead More
An effective vaccine is only the first step: the need to create and sustain demand for TB vaccinesFriday, August 9, 2024Acceptability, Acceptability and demand, Implementation strategies and feasibilityRead More
ACEITar: Evaluation of the acceptability of new and repurposed tuberculosis vaccines in Mozambique Friday, August 9, 2024Acceptability, Acceptability and demandRead More
Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.Friday, August 9, 2024Availability, Epidemiological impactRead More
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Implementation strategies and feasibilityRead More
Potential impact of tuberculosis vaccines in China, South Africa, and IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Formative work to understand factors affecting future TB vaccines acceptanceFriday, August 9, 2024Acceptability, Acceptability and demand, Acceptability and demand, Accessibility, Health system readiness, Health system readinessRead More
Foster political, advocacy for TB vaccines R&D, and enhanced community engagementFriday, August 9, 2024Acceptability, Community engagementRead More
Estimating the epidemiologic impact of new TB vaccines in high-burden settingsFriday, August 9, 2024Availability, Epidemiological impactRead More
Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
